CTIS.eu › Cities › Latvia › Liepaja
Liepaja
Latvia
43 total trials
17 recruiting
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2025-522586-30-00
5
Psoriatic Arthritis
2024-519343-15-00
5
2025-10-08
Low-grade Upper Tract Urothelial Cancer
2024-519423-24-00
5
2025-10-07
Major Depressive Disorder
2023-507853-13-00
4
2025-02-25
Ulcerative Colitis
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
2023-505678-14-00
4
2024-08-19
Ulcerative Colitis
2022-500273-14-00
10
2023-07-17
Atherosclerotic cardiovascular disease in patients with ESKD
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
2025-520478-20-00
5
2025-11-05
Thromboembolic disease
2024-519421-37-00
5
2025-08-28
Major Depressive Disorder
2024-519688-16-00
4
2025-08-07
venous thromboembolism
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
2024-513111-27-00
5
2025-06-26
Psoriatic Arthritis
2024-513009-30-00
4
2024-11-21
Moderate to Severe Crohn’s Disease
2023-508581-15-00
5
2024-10-08
Heart condition
2023-508158-24-00
4
2024-06-25
Moderately to Severely Active Crohn’s Disease
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
2022-501254-10-00
5
2018-08-24
Advanced tumors
2025-520488-42-00
4
2025-09-17
Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
2024-518998-33-00
5
2025-07-23
Ulcerative Colitis
2023-507261-25-00
5
2024-10-03
Nonmuscle Invasive Bladder Cancer
2023-503655-10-00
5
2023-11-20
Systemic Lupus Erythematosus (SLE).
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
Showing 1–24 of 43 trials